Logo image of AS

AMER SPORTS INC (AS) Stock Fundamental Analysis

NYSE:AS - New York Stock Exchange, Inc. - KYG0260P1028 - Common Stock - Currency: USD

37  -0.37 (-0.99%)

After market: 36.44 -0.56 (-1.51%)

Fundamental Rating

4

Taking everything into account, AS scores 4 out of 10 in our fundamental rating. AS was compared to 48 industry peers in the Textiles, Apparel & Luxury Goods industry. While AS is still in line with the averages on profitability rating, there are concerns on its financial health. AS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year AS was profitable.
AS had a positive operating cash flow in the past year.
AS had negative earnings in 4 of the past 5 years.
Of the past 5 years AS 4 years had a positive operating cash flow.
AS Yearly Net Income VS EBIT VS OCF VS FCFAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.87%, AS is in line with its industry, outperforming 41.67% of the companies in the same industry.
With a Return On Equity value of 1.45%, AS perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
With a Return On Invested Capital value of 5.14%, AS is not doing good in the industry: 60.42% of the companies in the same industry are doing better.
AS had an Average Return On Invested Capital over the past 3 years of 4.01%. This is significantly below the industry average of 13.46%.
The last Return On Invested Capital (5.14%) for AS is above the 3 year average (4.01%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.87%
ROE 1.45%
ROIC 5.14%
ROA(3y)-1.61%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.01%
ROIC(5y)N/A
AS Yearly ROA, ROE, ROICAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 -200

1.3 Margins

AS's Profit Margin of 1.41% is in line compared to the rest of the industry. AS outperforms 43.75% of its industry peers.
The Operating Margin of AS (8.54%) is comparable to the rest of the industry.
AS's Operating Margin has improved in the last couple of years.
AS has a Gross Margin of 55.26%. This is in the better half of the industry: AS outperforms 66.67% of its industry peers.
In the last couple of years the Gross Margin of AS has grown nicely.
Industry RankSector Rank
OM 8.54%
PM (TTM) 1.41%
GM 55.26%
OM growth 3Y14.18%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.11%
GM growth 5YN/A
AS Yearly Profit, Operating, Gross MarginsAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

More info and screens

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AS is destroying value.
AS has more shares outstanding than it did 1 year ago.
AS has a better debt/assets ratio than last year.
AS Yearly Shares OutstandingAS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 100M 200M 300M 400M 500M
AS Yearly Total Debt VS Total AssetsAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

AS has an Altman-Z score of 4.95. This indicates that AS is financially healthy and has little risk of bankruptcy at the moment.
AS's Altman-Z score of 4.95 is amongst the best of the industry. AS outperforms 83.33% of its industry peers.
The Debt to FCF ratio of AS is 10.85, which is on the high side as it means it would take AS, 10.85 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AS (10.85) is worse than 62.50% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that AS is not too dependend on debt financing.
AS's Debt to Equity ratio of 0.25 is fine compared to the rest of the industry. AS outperforms 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 10.85
Altman-Z 4.95
ROIC/WACC0.72
WACC7.14%
AS Yearly LT Debt VS Equity VS FCFAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

AS has a Current Ratio of 1.54. This is a normal value and indicates that AS is financially healthy and should not expect problems in meeting its short term obligations.
AS's Current ratio of 1.54 is on the low side compared to the rest of the industry. AS is outperformed by 68.75% of its industry peers.
AS has a Quick Ratio of 1.54. This is a bad value and indicates that AS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.76, AS is doing worse than 79.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 0.76
AS Yearly Current Assets VS Current LiabilitesAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

AS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.67%, which is quite impressive.
AS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.79%.
Measured over the past years, AS shows a quite strong growth in Revenue. The Revenue has been growing by 19.12% on average per year.
EPS 1Y (TTM)126.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%237.5%
Revenue 1Y (TTM)17.79%
Revenue growth 3Y19.12%
Revenue growth 5YN/A
Sales Q2Q%24.48%

3.2 Future

AS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.64% yearly.
AS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.24% yearly.
EPS Next Y59.54%
EPS Next 2Y45.14%
EPS Next 3Y38.93%
EPS Next 5Y34.64%
Revenue Next Year15.74%
Revenue Next 2Y14.45%
Revenue Next 3Y14.02%
Revenue Next 5Y13.24%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AS Yearly Revenue VS EstimatesAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
AS Yearly EPS VS EstimatesAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 58.73, which means the current valuation is very expensive for AS.
Based on the Price/Earnings ratio, AS is valued a bit more expensive than the industry average as 70.83% of the companies are valued more cheaply.
AS is valuated expensively when we compare the Price/Earnings ratio to 26.03, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 39.92 indicates a quite expensive valuation of AS.
Based on the Price/Forward Earnings ratio, AS is valued a bit more expensive than the industry average as 68.75% of the companies are valued more cheaply.
AS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.94.
Industry RankSector Rank
PE 58.73
Fwd PE 39.92
AS Price Earnings VS Forward Price EarningsAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

70.83% of the companies in the same industry are cheaper than AS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AS is valued a bit more expensive than 64.58% of the companies in the same industry.
Industry RankSector Rank
P/FCF 149.85
EV/EBITDA 30.52
AS Per share dataAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AS's earnings are expected to grow with 38.93% in the coming years.
PEG (NY)0.99
PEG (5Y)N/A
EPS Next 2Y45.14%
EPS Next 3Y38.93%

More info and screens

0

5. Dividend

5.1 Amount

AS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMER SPORTS INC

NYSE:AS (5/21/2025, 7:57:17 PM)

After market: 36.44 -0.56 (-1.51%)

37

-0.37 (-0.99%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-20 2025-05-20/bmo
Earnings (Next)N/A N/A
Inst Owners32.62%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.48B
Analysts82.5
Price Target32.24 (-12.86%)
Short Float %7.25%
Short Ratio3.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.09%
Min EPS beat(2)-2.6%
Max EPS beat(2)32.79%
EPS beat(4)3
Avg EPS beat(4)117.38%
Min EPS beat(4)-2.6%
Max EPS beat(4)253.05%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.21%
Min Revenue beat(2)-0.76%
Max Revenue beat(2)1.18%
Revenue beat(4)3
Avg Revenue beat(4)0.93%
Min Revenue beat(4)-0.76%
Max Revenue beat(4)1.75%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.3%
PT rev (3m)3.93%
EPS NQ rev (1m)1.78%
EPS NQ rev (3m)-8.69%
EPS NY rev (1m)-0.41%
EPS NY rev (3m)-1.27%
Revenue NQ rev (1m)0.21%
Revenue NQ rev (3m)0.28%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 58.73
Fwd PE 39.92
P/S 3.97
P/FCF 149.85
P/OCF 48.23
P/B 4.1
P/tB 72.77
EV/EBITDA 30.52
EPS(TTM)0.63
EY1.7%
EPS(NY)0.93
Fwd EY2.51%
FCF(TTM)0.25
FCFY0.67%
OCF(TTM)0.77
OCFY2.07%
SpS9.33
BVpS9.03
TBVpS0.51
PEG (NY)0.99
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.87%
ROE 1.45%
ROCE 6.51%
ROIC 5.14%
ROICexc 5.42%
ROICexgc 20.29%
OM 8.54%
PM (TTM) 1.41%
GM 55.26%
FCFM 2.65%
ROA(3y)-1.61%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.01%
ROIC(5y)N/A
ROICexc(3y)4.27%
ROICexc(5y)N/A
ROICexgc(3y)18.87%
ROICexgc(5y)N/A
ROCE(3y)5.08%
ROCE(5y)N/A
ROICexcg growth 3Y16.69%
ROICexcg growth 5YN/A
ROICexc growth 3Y36.01%
ROICexc growth 5YN/A
OM growth 3Y14.18%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.11%
GM growth 5YN/A
F-Score8
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 10.85
Debt/EBITDA 1.72
Cap/Depr 105.19%
Cap/Sales 5.57%
Interest Coverage 2.24
Cash Conversion 59.38%
Profit Quality 188.29%
Current Ratio 1.54
Quick Ratio 0.76
Altman-Z 4.95
F-Score8
WACC7.14%
ROIC/WACC0.72
Cap/Depr(3y)81.5%
Cap/Depr(5y)67.78%
Cap/Sales(3y)4.31%
Cap/Sales(5y)4.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%237.5%
EPS Next Y59.54%
EPS Next 2Y45.14%
EPS Next 3Y38.93%
EPS Next 5Y34.64%
Revenue 1Y (TTM)17.79%
Revenue growth 3Y19.12%
Revenue growth 5YN/A
Sales Q2Q%24.48%
Revenue Next Year15.74%
Revenue Next 2Y14.45%
Revenue Next 3Y14.02%
Revenue Next 5Y13.24%
EBIT growth 1Y50.29%
EBIT growth 3Y36.01%
EBIT growth 5YN/A
EBIT Next Year75.37%
EBIT Next 3Y33.93%
EBIT Next 5Y24.7%
FCF growth 1Y189.62%
FCF growth 3Y-6.84%
FCF growth 5YN/A
OCF growth 1Y113.42%
OCF growth 3Y16.59%
OCF growth 5YN/A